Jaguar Health, Inc. (JAGX)

Market price: $2.10

6 methods not shown

• EV / EBITDA: EBITDA is non-positive — an EBITDA multiple yields no meaningful enterprise value (loss-making at the EBITDA line)
• EV / Revenue: minority interest / preferred stock rank ahead of common but could not be read — cannot bridge enterprise value to equity without overstating what common owns
• EV / Gross Profit: no multiple band available for EV / Gross Profit — supplied with market data (peer comps / own history)
• P / E: diluted EPS is non-positive — P/E is not meaningful for a loss-making period
• P / B: the market prices this company far outside its sector's P / B range (its own multiple is 0.02 vs a sector band of 5.75–10.69) — a sector-average bar would be misleading here, so it is withheld
• DCF (FCFF): DCF input(s) unavailable (capex) — cannot build FCFF

Pre-profit company — earnings-based methods not meaningful.

We can't show a valuation range for this company yet — we have its financial data, but not a peer group we can stand behind to compare it against, and the methods that apply here price a company against comparable companies.